Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma
The DOI matches its Crossref record; 30 of the 31 references it cites were found in a registry or an index.
Abstract
Stress can alter immunological, neurochemical and endocrinological functions, but its role in cancer progression is not well understood. Here, we show that chronic behavioral stress results in higher levels of tissue catecholamines, greater tumor burden and more invasive growth of ovarian carcinoma cells in an orthotopic mouse model. These effects are mediated primarily through activation of the tumor cell cyclic AMP (cAMP)-protein kinase A (PKA) signaling pathway by the beta(2) adrenergic receptor (encoded by ADRB2). Tumors in stressed animals showed markedly increased vascularization and enhanced expression of VEGF, MMP2 and MMP9, and we found that angiogenic processes mediated the effects of stress on tumor growth in vivo. These data identify beta-adrenergic activation of the cAMP-PKA signaling pathway as a major mechanism by which behavioral stress can enhance tumor angiogenesis in vivo and thereby promote malignant cell growth. These data also suggest that blocking ADRB-mediated angiogenesis could have therapeutic implications for the management of ovarian cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Parallel findings in animal and in vitro models support these data [11, 16–22].”
From Living Well: Protocol for a web-based program to improve quality of life in rural and urban ovarian cancer survivors (2024) · cites this paper as [16]
In the citing paper
“The tumor-promoting effect of catecholamines is mainly mediated by the β2 adrenergic receptor (encoded by ADRB2) activating the cAMP-protein kinase A (PKA) signaling pathway, which is the main mechanism to enhance tumor angiogenesis in the body and promote the growth of malignant cells [(34, 35); Figure 2].”
From Chronic Stress Promotes Cancer Development (2020) · cites this paper as [34]
In the citing paper
“Parallel effects have been observed in experimental animal models of cancer, and those analyses again identify a prominent role for SNS activation of β-adrenergic signaling [43], [44].”
From Human Social Genomics (2014) · cites this paper as [43]
Citations
Cites
Protective and Damaging Effects of Stress Mediators
McEwen, B. S. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801153380307 · Cited by 6,733
The Concepts of Stress and Stress System Disorders: Overview of Physical and Behavioral Homeostasis
Chrousos, G. P. (1992) · JAMA · doi:10.1001/jama.1992.03480090092034 · Cited by 2,689 · cited 1×
“Pharmacologic and genetic manipulations identify β-adrenergic signaling as a central mediator of stress effects in the model of stress used here, but these findings do not rule out the possibility that other neuroendocrine signaling pathways might modulate tumor cell biology under other circumstances (for example, str…”
BackgroundStress-induced immune dysfunction: implications for health
Glaser, R., & Kiecolt-Glaser, J. K. (2005) · Nature Reviews Immunology · doi:10.1038/nri1571 · Cited by 2,190 · cited 1×
“Previous research emphasized the role of the immune system in mediating stress effects on tumor growth and metastasi”
Stress, depression, the immune system, and cancer
Reiche, E. M. V., Nunes, S. O. V., & Morimoto, H. K. (2004) · The Lancet Oncology · doi:10.1016/s1470-2045(04)01597-9 · Cited by 1,364
The influence of bio-behavioural factors on tumour biology: pathways and mechanisms
Antoni, M. H., Lutgendorf, S. K., Cole, S. W., Dhabhar, F. S., Sephton, S. E., McDonald, P. G., Stefanek, M., & Sood, A. K. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1820 · Cited by 981
Self-citationPassaniti, A., Taylor, R. M., Пили, Р., Guo, Y., Long, P., Haney, J. A., Pauly, R. R., Grant, D. S., & Martin, G. R. (1992) · PubMed · Cited by 806
Therapeutic EphA2 Gene Targeting In vivo Using Neutral Liposomal Small Interfering RNA Delivery
Landen, C. N., Chavez-Reyes, A., Bucana, C., Schmandt, R., Deavers, M. T., Lopez-Berestein, G., & Sood, A. K. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0530 · Cited by 675 · cited 1×
“To facilitate in vivo distribution, we incorporated the siRNA into a neutral liposome, DOP”
MethodSelf-citationBasu, S., Nagy, J. A., Pal, S., Vasile, E., Eckelhoefer, I. A., Susan Bliss, V., Manseau, E. J., Dasgupta, P. S., Dvorak, H. F., & Mukhopadhyay, D. (2001) · Nature Medicine · doi:10.1038/87895 · Cited by 396
Social support, psychological distress, and natural killer cell activity in ovarian cancer
Lutgendorf, S. K., Sood, A. K., Anderson, B., McGinn, S., Maiseri, H., Dao, M., Sorosky, J. I., De Geest, K., Ritchie, J., & Lubaroff, D. M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.10.015 · Cited by 345 · cited 1×
“Previous research emphasized the role of the immune system in mediating stress effects on tumor growth and metastasi”
BackgroundSelf-citationLutgendorf, S. K., Cole, S. W., Costanzo, E. S., Bradley, S., Coffin, J. E., Jabbari, S., Rainwater, K. K., Ritchie, J. M., Yang, M., & Sood, A. K. (2003) · PubMed · Cited by 330
Self-citation
Research works printed but not linked: 1
- Halder, J. et al. Focal adhesion kinase targeting for therapy of ovarian carcinoma using in vivo siRNA delivery in neutral liposomes. Clin. Cancer Res. (in the press).
Cited by
Items 301–400 of 1,000
Pan, C., Wu, J., Zheng, S., Sun, H., Fang, Y. V., Huang, Z., Shi, M., Li, L., Bin, J., Liao, Y., et al. (2021) · 癌症:英文版 · doi:10.1002/cac2.12198 · Cited by 76
Zhi, X., Li, B., Li, Z., Zhang, J., Yu, J., Zhang, L., & Xu, Z. (2019) · International Journal of Oncology · doi:10.3892/ijo.2019.4753 · Cited by 66
“For β-blockade, Alzet osmotic minipumps (Durect Corporation, Cupertino, CA, USA) containing PBS or 2 mg/kg/d propranolol hydrochloride (Sigma-Aldrich; Merck KGaA, Darmstadt, Germany) were inserted on the nape of the neck 7 days prior to the initiation of restraint stress (9).”
BackgroundMethodCarvedilol use is associated with reduced cancer risk: A nationwide population-based cohort study
Lin, C., Lin, W., Lin, C., & Kao, C. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.02.015 · Cited by 72
Frumovitz, M., & Sood, A. K. (2007) · Gynecologic Oncology · doi:10.1016/j.ygyno.2006.10.062 · Cited by 73
“We have recently demonstrated that chronic behavioral stress can also promote VEGF production via stimulation of the βnergic receptor (encoded by ADRB2) on ovarian cancer cells [10].”
BackgroundSelf-citationα2-Adrenergic blockade mimics the enhancing effect of chronic stress on breast cancer progression
Lamkin, D. M., Sung, H. Y., Yang, G. S., David, J., Ma, J. C. Y., Cole, S. W., & Sloan, E. K. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.10.004 · Cited by 67
“Experimental studies of stress effects in preclinical mouse models of breast cancer have shown that chronic restraint can increase the rate of primary tumor growth (Thaker et al., 2006) or cause primary tumor to become more metastatic (Sloan et al., 2010).”
BackgroundResultInfluentialSelf-citationImpact of beta-blockers on prostate cancer mortality: a meta-analysis of 16,825 patients
Lu, H., Liu, X., Guo, F., Tan, S., Wang, G., Liu, H., Wang, J., He, X., Mo, Y., & Shi, B. (2015) · OncoTargets and Therapy · doi:10.2147/ott.s78836 · Cited by 69
“The main mediator of these effects is thought to be ADRB2.(7,8) The signaling pathways of the ADRBs have also been suggested to be involved in the immune system’s response to cancer, in addition to having effects on angiogenesis and cancer cell”
Jang, H.-J., Boo, H., Lee, H. J., Min, H.-Y., & Lee, H. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0990 · Cited by 71
Chronic stress accelerates the development of endometriosis in mouse through adrenergic receptor β2
Long, Q., Liu, X., Qi, Q., & Guo, S.-W. (2016) · Human Reproduction · doi:10.1093/humrep/dew237 · Cited by 64
β 3 ‐Adrenoceptor as a potential immuno‐suppressor agent in melanoma
Calvani, M., Bruno, G., Monte, M. D., Nassini, R., Fontani, F., Casini, A., Cavallini, L., Becatti, M., Bianchini, F., Logu, F. D., et al. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14660 · Cited by 69
Chaudhary, K. R., Yan, S. X., Heilbroner, S. P., Sonett, J. R., Stoopler, M. B., Shu, C. A., Halmos, B., Wang, T. J. C., Hei, T. K., & Cheng, S. K. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8050575 · Cited by 66
“Experiments in colon carcinoma cell line showed that β-AR signals through phospholipase C and protein kinase C and membrane metalloproteinases to induce cellular migration [23,38,39].”
BackgroundXie, H., Li, C., He, Y., Griffin, R., Ye, Q., & Li, L. (2015) · Oral Oncology · doi:10.1016/j.oraloncology.2015.08.007 · Cited by 68
“A mouse restraint system was utilized for physical immobilization of the animal to cause chronic stress experimentally [1].”
BackgroundMethodInfluentialTargeting Aurora Kinase with MK-0457 Inhibits Ovarian Cancer Growth
Lin, Y. G., Immaneni, A., Merritt, W. M., Mangala, L. S., Kim, S. W., Shahzad, M. M. K., Tsang, Y. T. M., Armaiz-Peña, G. N., Lu, C., Kamat, A. A., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4922 · Cited by 68
Self-citationNew copper complexes inducing bimodal death through apoptosis and autophagy in A549 cancer cells
Gul, N. S., Khan, T.-M., Chen, M., Huang, K.-B., Hou, C., Choudhary, M. I., Liang, H., & Chen, Z. (2020) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2020.111260 · Cited by 66
Løfling, L. L., Støer, N. C., Sloan, E. K., Chang, A., Gandini, S., Ursin, G., & Botteri, E. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-01891-7 · Cited by 59
“β-adrenergic signalling is involved in various processes during tumour progression, including suppression of antitumor immunity [5, 6], vasculature remodelling [7, 8], and tumour cell dissemination [9, 10].”
BackgroundStress, inflammation, and eicosanoids: an emerging perspective
Umamaheswaran, S., Dasari, S. K., Yang, P., Lutgendorf, S. K., & Sood, A. K. (2018) · Cancer and Metastasis Reviews · doi:10.1007/s10555-018-9741-1 · Cited by 72
Self-citationPsychological distress and eustress in cancer and cancer treatment: Advances and perspectives
Wu, Y., Zhou, L., Zhang, X., Yang, X., Niedermann, G., & Xue, J. (2022) · Science Advances · doi:10.1126/sciadv.abq7982 · Cited by 74
Huang, Q., Hu, B., Ping, Z., Yuan, Y., Yue, S., Chen, X., Liang, J., Tang, Z., & Zhang, B. (2025) · Molecular Cancer · doi:10.1186/s12943-024-02219-0 · Cited by 76
Kang, F., Ma, W., Ma, X., Shao, Y., Yang, W., Chen, X. S., Li, L., & Wang, J. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.121327 · Cited by 69
The Effect of Psychological Stress and Social Isolation on Neuroimmunoendocrine Communication
Cruces, J., Venero, C., Pereda-Pérez, I., & la Fuente, M. D. (2014) · Current Pharmaceutical Design · doi:10.2174/1381612820666140130205822 · Cited by 76
Liu, X., Wu, W. K. K., Yu, L., Sung, J. J. �., Srivastava, G., Zhang, S. T., & Cho, C. H. (2008) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21802 · Cited by 63
“…COX-2 EXPRESSION WHICH WERE ABOLISHED BY b-ADRENOCEPTOR ANTAGONISTS Previous studies showed that phosphorylation of ERK1/2 and the subsequent activation of arachidonic acid cascade were involved in the stimulation of cell proliferation [Fan et al., 2001; Souza et al., 2004; Tominaga et al., 2004].”
BackgroundAdrenergic-mediated increases in INHBA drive CAF phenotype and collagens
Nagaraja, A. S., Dood, R. L., Armaiz-Peña, G. N., Kang, Y., Wu, S. Y., Allen, J. K., Jennings, N. B., Mangala, L. S., Pradeep, S., Lyons, Y., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.93076 · Cited by 65
“Chronic stress was induced experimentally by using a restraint-stress procedure that has been previously described (20).”
MethodSelf-citationCommon cardiovascular medications in cancer therapeutics
Vaklavas, C., Chatzizisis, Y. S., & Tsimberidou, A. M. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.01.009 · Cited by 68
What Is the Brain-Cancer Connection?
Cao, L., & During, M. J. (2012) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-062111-150546 · Cited by 69
Zhou, J., Liu, Z., Zhang, L., Hu, X., Wang, Z., Ni, H., Wang, Y., & Qin, J. (2020) · Cancer Research and Treatment · doi:10.4143/crt.2019.510 · Cited by 59
Bone metastases: a comprehensive review of the literature
Migliorini, F., Maffulli, N., Trivellas, A., Eschweiler, J., Tingart, M., & Driessen, A. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-05684-0 · Cited by 67
Fraterman, I., Reijers, I. L. M., Dimitriadis, P., Broeks, A., Gonzalez, M., Menzies, A. M., López‐Yurda, M., Kapiteijn, E., van der Veldt, A. A. M., Suijkerbuijk, K. P. M., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02631-x · Cited by 74
“…that stress affects the tumor and its microenvironment by promoting tumor cell initiation 30,31 , proliferation and metastasis 32,33 , angiogenesis 34,35 , inflammation 13,36 and immune evasion 18–23 Besides the direct effects of stress on tumor progression, one may argue that stress could also…”
Impact of vessel maturation on antiangiogenic therapy in ovarian cancer
Lü, C., Thaker, P. H., Lin, Y. G., Spannuth, W. A., Landen, C. N., Merritt, W. M., Jennings, N. B., Langley, R. R., Gershenson, D. M., Yancopoulos, G. D., et al. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2007.12.028 · Cited by 62
Self-citationIntegrative Oncology: An Overview
Deng, G. E., & Cassileth, B. R. (2014) · American Society of Clinical Oncology Educational Book · doi:10.14694/edbook_am.2014.34.233 · Cited by 70
Flint, M. S., Baum, A. E., Episcopo, B., Knickelbein, K. Z., Dougall, A. L., Chambers, W. H., & Jenkins, F. J. (2012) · Stress · doi:10.3109/10253890.2012.686075 · Cited by 65
Tumor progression: the neuronal input
Arese, M., Bussolino, F., Pergolizzi, M., Bizzozero, L., & Pascal, D. (2018) · Annals of Translational Medicine · doi:10.21037/atm.2018.01.01 · Cited by 63
“The circulation levels of epinephrine and norepinephrine increases during psychological stress and depression favoring the initiation of cancer (39), while β-blockers have preventive effects in the development of cancer in different models, for example ovarian cancer and pancreatic ductal adenocarcinoma in mice (74,81…”
BackgroundGenetic diversity, inbreeding and cancer
Újvári, B., Klaassen, M., Raven, N., Russell, T., Vittecoq, M., Hamede, R., Frédéric Thomas, A., & Madsen, T. R. L. (2018) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.2017.2589 · Cited by 69
EGFR/HER-Targeted Therapeutics In Ovarian Cancer
Wilken, J. A., Badri, T., Cross, S., Raji, R., Santin, A. D., Schwartz, P. E., Branscum, A. J., Baron, A. T., Sakhitab, A. I., & Maihle, N. J. (2012) · Future Medicinal Chemistry · doi:10.4155/fmc.12.11 · Cited by 69
Not miR-ly small RNAs: Big potential for microRNAs in therapy
Love, T. M., Moffett, H. F., & Novina, C. D. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.12.1167 · Cited by 67
The effect of chronic stress on anti-angiogenesis of sunitinib in colorectal cancer models
Liu, J., Deng, G.-H., Zhang, J., Wang, Y., Xia, X.-Y., Luo, X., Deng, Y., He, S., Mao, Y., Peng, X., et al. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.11.008 · Cited by 65
“…(IL-8) and matrix metalloproteinases (MMPs) by direct activating - adrenoceptors (Lutgendorf et al., 2003; Yang et al., 2006, 2009; Shahzad et al., 2010), by which chronic stress can enhance tumor angiogenesis and progression (Palm et al., 2006; Thaker et al., 2006; Shahzad et al., 2010).”
BackgroundMethodHorváthová, Ľ., Padová, A., Tillinger, A., Osacká, J., Bízik, J., & Mravec, B. (2016) · Stress · doi:10.1080/10253890.2016.1213808 · Cited by 63
“…Godbout & Glaser, 2006; Hou et al., 2013; Valles et al., 2013) and directly, by modulating the function of non-immune cells localized in the tumor microenvironment, including the cancer cells themselves (Chakroborty et al., 2009; Sood et al., 2006; Thaker et al., 2006; Tilan & Kitlinska, 2010).”
BackgroundSun, X. K., Chen, X., Zhao, J., Ma, C., Yan, C., Liswaniso, S., Xu, R., & Qin, N. (2021) · BMC Genomics · doi:10.1186/s12864-021-08213-w · Cited by 74
Biobehavioral Pathways and Cancer Progression: Insights for Improving Well-Being and Cancer Outcomes
Chang, A., Sloan, E. K., Antoni, M. H., Knight, J. M., Telles, R., & Lutgendorf, S. K. (2022) · Integrative Cancer Therapies · doi:10.1177/15347354221096081 · Cited by 64
Self-citationPerioperative Immunosuppressive Factors during Cancer Surgery: An Updated Review
Bezu, L., Öksüz, D. A., Bell, M., Buggy, D. J., Díaz‐Cambronero, Ó., Enlund, M., Forget, P., Gupta, A. K., Hollmann, M. W., Ionescu, D. C., et al. (2024) · Cancers · doi:10.3390/cancers16132304 · Cited by 69
“Surprisingly, mice subjected to the same stressed conditions and treated with propranolol showed an abolition of angiogenesis [61].”
BackgroundEffect of Chronic Restraint Stress on Human Colorectal Carcinoma Growth in Mice
Lin, Q., Wang, F., Yang, R., Zheng, X., Gao, H.-B., & Zhang, P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061435 · Cited by 67
“Stress hormones might directly regulate the growth and metastatic potential of tumor cells, and this effect might be independent of the immune system [22].”
BackgroundMethodInfluentialMedeiros, P. J., & Jackson, D. N. (2013) · Peptides · doi:10.1016/j.peptides.2013.07.029 · Cited by 68
Mind-Body Practices in Cancer Care
Chaoul, A., Milbury, K., Sood, A. K., Prinsloo, S., & Cohen, L. G. (2014) · Current Oncology Reports · doi:10.1007/s11912-014-0417-x · Cited by 70
Self-citationSchwann cells: a new player in the tumor microenvironment
Bunimovich, Y. L., Keskinov, A. A., Shurin, G. V., & Shurin, M. R. (2016) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-016-1929-z · Cited by 65
Lu, D., Andrae, B., Valdimarsdóttir, U. A., Sundström, K., Fall, K., Sparén, P., & Fang, F. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-0116 · Cited by 68
“For instance, the adrenergic signaling pathway activated by stress may upregulate vascular endothelial growth factor to increase angiogenesis around the tumor and subsequently facilitate tumor growth (46).”
BackgroundStress affects uterine receptivity through an ovarian-independent pathway
Kondoh, E., Okamoto, T., Higuchi, T., Tatsumi, K., Baba, T., Murphy, S. K., Takakura, K., Konishi, I., & Fujii, S. (2008) · Human Reproduction · doi:10.1093/humrep/den461 · Cited by 62
Ferrer, R. A., Green, P. A., & Barrett, L. F. (2015) · Perspectives on Psychological Science · doi:10.1177/1745691615576755 · Cited by 58
“For example, negative affective states often involve strong beta-adrenergic sympathetic nervous system activity that, in nonhuman animal models, encourages cancer cell replication (Irwin & Cole, 2011; Reiche, Nunes, & Morimoto, 2004; Thaker et al., 2006).”
Propranolol suppresses gastric cancer cell growth by regulating proliferation and apoptosis
Koh, M., Takahashi, T., Kurokawa, Y., Kobayashi, T., Saito, T., Ishida, T., Serada, S., Fujimoto, M., Naka, T., Wada, N., et al. (2021) · Gastric Cancer · doi:10.1007/s10120-021-01184-7 · Cited by 61
“These effects are mediated primarily through activation of the tumor cell cAMP signaling pathway by β2-AR [37].”
BackgroundClinical and biological relevance of enhancer of zeste homolog 2 in triple-negative breast cancer
Hussein, Y. R., Sood, A. K., Bandyopadhyay, S., Albashiti, B., Semaan, A. Y., Nahleh, Z. A., Roh, J., Han, H. D., Lopez‐Berestein, G., & Ali‐Fehmi, R. (2012) · Human Pathology · doi:10.1016/j.humpath.2011.12.004 · Cited by 60
“MB-231 TNBC cells (5 × 106) were injected into the mammary fat pad of mice as described previously [15].”
MethodSelf-citationRegulation of Cancer Progression by β-Endorphin Neuron
Sarkar, D. K., Murugan, S., Zhang, C., & Boyadjieva, N. I. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3292 · Cited by 68
Beta-adrenergic blocking drugs in breast cancer: a perspective review
Barron, T. I., Sharp, L., & Visvanathan, K. (2012) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758834012439738 · Cited by 67
“2000; Carie and Sebti, 2007] and promote breast tumour growth [Re et al. 1992; Cakir et al. 2002; Thaker et al. 2006; Shi et al. 2011], and more recent studies report that β-AR”
BackgroundResultInfluentialIs Posthospital Syndrome a Result of Hospitalization-Induced Allostatic Overload?
Goldwater, D. S., Dharmarajan, K., McEwen, B. S., & Krumholz, H. M. (2018) · Journal of Hospital Medicine · doi:10.12788/jhm.2986 · Cited by 64
Murine hematopoietic stem cells and progenitors express adrenergic receptors
Muthu, K., Iyer, S., He, L.-K., Szilágyi, A., Gamelli, R. L., Shankar, R., & Jones, S. B. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.02.007 · Cited by 65
The Calm Mouse: An Animal Model of Stress Reduction
Gurfein, B. T., Stamm, A. W., Bacchetti, P., Dallman, M. F., Nadkarni, N. A., Milush, J. M., Touma, C., Palme, R., di Borgo, C. P., Fromentin, G., et al. (2012) · Molecular Medicine · doi:10.2119/molmed.2012.00053 · Cited by 66
Shan, T., Ma, Q., Zhang, D., Guo, K., Liu, H., Wang, F., & Wu, E. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.04.055 · Cited by 57
Norepinephrine induced epithelial–mesenchymal transition in HT-29 and A549 cells in vitro
Zhang, J., Deng, Y., Liu, J., Wang, Y., Yi, T., Huang, B., He, S., Zheng, B., & Jiang, Y. (2015) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-015-2044-9 · Cited by 58
Filippi, L., Cavallaro, G., Fiorini, P., Daniotti, M., Benedetti, V., Cristofori, G., Araimo, G., Ramenghi, L. A., Torre, A. L., Fortunato, P., et al. (2010) · BMC Pediatrics · doi:10.1186/1471-2431-10-83 · Cited by 57
“This proangiogenic effect is antagonized by propranolol [46-54].”
Roberts, A. L., Huang, T., Koenen, K. C., Kim, Y., Kubzansky, L. D., & Tworoger, S. S. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-1222 · Cited by 65
“, norepinephrine) increases their invasiveness (3, 8, 9).”
BackgroundInfluentialNo evidence that social stress is associated with breast cancer incidence
Surtees, P. G., Wainwright, N. W. J., Luben, R., Khaw, K., & Bingham, S. A. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0454-6 · Cited by 66
“This view is supported by animal model– based psychoneuroimmunological evidence concerning the effects of behavioural stress on tumorigenesis and the biological mechanisms involved [5–7].”
ResultADRB2-Targeting Therapies for Prostate Cancer
Kulik, G. (2019) · Cancers · doi:10.3390/cancers11030358 · Cited by 57
“In the mouse models of prostate and ovarian cancers immobilization stress increased both Epi and NE in cancer xenografts, and prostate glands [27,61].”
BackgroundCatecholamines in the regulation of angiogenesis in cutaneous wound healing
Chakroborty, D., Goswami, S., Basu, S., & Sarkar, C. (2020) · The FASEB Journal · doi:10.1096/fj.202001701r · Cited by 60
Balakin, E. I., Yurku, K. A., Ivanov, M., Izotov, A., Игоревна, Н. В., & Pustovoit, V. I. (2025) · Biology · doi:10.3390/biology14010076 · Cited by 84
Livingstone, E., Hollestein, L. M., van Herk‐Sukel, M. P. P., van de Poll-Franse, L. V., Nijsten, T. E. C., Schadendorf, D., & de Vries, E. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.07.141 · Cited by 60
Curtin, N. M., Mills, K. H. G., & Connor, T. J. (2009) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2008.12.010 · Cited by 65
“However, a 2 h restraint time was chosen as this has been shown to be sufficient to result in immunomodulation (Thanker et al., 2006).”
BackgroundLee, Y.-Y., Jeon, H., Hong, J. E., Cho, Y., Ryu, J., Choi, J., Lee, S. H., Yoon, G., Kim, W. Y., Do, I., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5319 · Cited by 60
“2 mL HBSS) were injected into the peritoneal cavity of mice [33].”
Self-citationTemozolomide arrests glioma growth and normalizes intratumoral extracellular pH
Rao, J. U., Coman, D., Walsh, J. J., Ali, M. M., Huang, Y., & Hyder, F. (2017) · Scientific Reports · doi:10.1038/s41598-017-07609-7 · Cited by 56
Wang, Y., Wang, X., Wang, K., Qi, J., Zhang, Y., Wang, X., Zhang, L., Zhou, Y., Gu, L., Yu, R., et al. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02728-8 · Cited by 55
“The CUMS and CRS procedures were performed as previously described [5, 14] with certain modifications.”
MethodFrick, L. R., Rapanelli, M., Bussmann, U. A., Klecha, A. J., Arcos, M. L. B., Genaro, A. M., & Cremaschi, G. A. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.12.013 · Cited by 55
Neuroendocrine Regulation of Tumor-Associated Immune Cells
Colón-Echevarria, C. B., Lamboy-Caraballo, R., Aquino-Acevedo, A. N., & Armaiz-Peña, G. N. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01077 · Cited by 62
“Additionally, a study that utilized orthotopic mice models of ovarian cancer found that immobilization stress stimulated tumor production of VEGF, leading to increased tumor burden (7).”
BackgroundFukumitsu, K., Kaneko, M., Maruyama, T., Yoshihara, C., Huang, A. J. Y., McHugh, T. J., Itohara, S., Tanaka, M., & Kuroda, K. O. (2022) · Nature Communications · doi:10.1038/s41467-022-28131-z · Cited by 57
Dopamine receptor antagonist thioridazine inhibits tumor growth in a murine breast cancer model
Yin, T., He, S., Shen, G., Ye, T., Guo, F., & Wang, Y. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.3967 · Cited by 59
“…of the cyclic adenosine monophos-phate‑protein kinase A signaling pathway has been reported to enhance tumor angiogenesis in vivo and promote malignant cell growth (2). β ‑blockers have been shown to reduce recurrence rates and mortality in patients with breast, melanoma and prostate cancer (3‑5).”
BackgroundTumor Suppressive Effects of Bromodomain-Containing Protein 7 (BRD7) in Epithelial Ovarian Carcinoma
Park, Y.-A., Lee, J., Kim, H., Lee, Y.-Y., Kim, T., Choi, C. H., Choi, J., Jeon, H., Cho, Y., Ryu, J., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1271 · Cited by 57
“2 mL HBSS) were injected into the peritoneal cavity (17).”
MethodSelf-citationPrometastatic Molecular Profiles in Breast Tumors From Socially Isolated Women
Bower, J. E., Shiao, S. L., Sullivan, P., Lamkin, D. M., Atienza, R., Mercado, F., Arevalo, J. M. G., Asher, A., Ganz, P. A., & Cole, S. W. (2018) · JNCI Cancer Spectrum · doi:10.1093/jncics/pky029 · Cited by 56
“Both of these dynamics have been observed in previous preclinical cancer models in which animals are exposed to chronic stress (18,43).”
Self-citationAsh, S. A., & Buggy, D. J. (2013) · Best practice & research. Clinical anaesthesiology · doi:10.1016/j.bpa.2013.10.005 · Cited by 60
Psychosocial factors and hematopoietic stem cell transplantation: Potential biobehavioral pathways
Knight, J. M., Lyness, J. M., Sahler, O. J. Z., Liesveld, J. L., & Moynihan, J. A. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2013.06.016 · Cited by 62
“Though there are no studies directly evaluating the effects of psychosocial factors on VEGF in HCT recipients, chronic behavioral stress in mice results in markedly increased vascularization and VEGF expression in ovarian tumor cells (Thaker et al., 2006).”
BackgroundPromising approaches of small interfering RNAs (siRNAs) mediated cancer gene therapy
Senapati, D., Patra, B. C., Kar, A., Chini, D. S., Ghosh, S., Patra, S., & Bhattacharya, M. (2019) · Gene · doi:10.1016/j.gene.2019.144071 · Cited by 59
Zhang, B., Wu, C., Chen, W., Qiu, L., Li, S., Wang, T., Xie, H., Li, Y., Li, C., & Li, L. (2020) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2020.104712 · Cited by 59
Self-citationChronic Psychological Stress Induces the Accumulation of Myeloid-Derived Suppressor Cells in Mice
Jin, J., Wang, X., Wang, Q., Guo, X., Cao, J., Zhang, X., Zhu, T., Zhang, D., Wang, W., Wang, J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074497 · Cited by 53
“Mice subjected to ≥ four 12-h restraint sessions have been demonstrated to suffer from chronic psychological stress [2,3,7,9,11,14,15].”
BackgroundMethodInfluentialMinding the body: Psychotherapy and cancer survival
Spiegel, D. (2014) · British Journal of Health Psychology · doi:10.1111/bjhp.12061 · Cited by 53
The anti-cancer effects of itraconazole in epithelial ovarian cancer
Choi, C. H., Ryu, J.-Y., Cho, Y.-J., Jeon, H.-K., Choi, J.-J., Ylaya, K., Lee, Y.-Y., Kim, T.-J., Chung, J.-Y., Hewitt, S. M., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-06510-7 · Cited by 53
Self-citationThe Relationship Between Regional Anesthesia and Cancer: A Metaanalysis.
Grandhi, R. K., Lee, S. J., & Abd-Elsayed, A. A. (2017) · PubMed · Cited by 55
Role of the Nervous System in Tumor Angiogenesis
Kuol, N., Stojanovska, L., Apostolopoulos, V., & Nurgali, K. (2018) · Cancer Microenvironment · doi:10.1007/s12307-018-0207-3 · Cited by 58
Rosso, M. E. D., Sterle, H., Cremaschi, G., & Genaro, A. M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01341 · Cited by 55
“Experimental analyses in animal models have found that behavioral stress induced an accelerated progression of pancreatic (56), prostate (57), breast (58), and ovarian (12) carcinomas and malignant melanomas (59).”
BackgroundFlaherty, R. L., Intabli, H., Falcinelli, M., Bucca, G., Hesketh, A. R., Patel, B. A., Allen, M. C., Smith, C. P. S., & Flint, M. S. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.05.027 · Cited by 59
Al-Wadei, H. A. N., & Schuller, H. M. (2009) · The Journal of Pathology · doi:10.1002/path.2542 · Cited by 52
“These findings are in accord with reports on significant stimulating effects of these stress neurotransmitters on the proliferation and metastasis of adenocarcinoma of the colon [26,27], stomach [25], prostate [28], and ovary [29,30].”
He, Z., Wei, X., Luo, M., Luo, S., Yang, Y., Yu, Y.-Y., Chen, Y., Ma, C., Liang, X., Guo, F., et al. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.10.015 · Cited by 53
Self-citationNeuroendocrine Factors and Head and Neck Squamous Cell Carcinoma: An Affair to Remember
Solomon, I., Voiculescu, V. M., Căruntu, C., Lupu, M., Popa, A. V., Ilie, M. A., Albulescu, R., Căruntu, A., Tănase, C., Constantin, C., et al. (2018) · Disease Markers · doi:10.1155/2018/9787831 · Cited by 55
“Conditions such as depression, anxiety, and chronic stress can lead to an imbalance of the HPA axis [51, 52] and an increase of proinflammatory cytokines such as IL-6 [53].”
BackgroundInfluentialMolecular crosstalk between Y5 receptor and neuropeptide Y drives liver cancer
Dietrich, P., Wormser, L., FRITZ, V. K., Seitz, T., Maria, M. D., Schambony, A., Kremer, A. E., Günther, C., Itzel, T., Thasler, W. E., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci131919 · Cited by 59
“Moreover, sympathoadrenergic signaling has emerged as a strong promoter of several cancer types (10-13).”
BackgroundIncreasing Area Deprivation Index negatively impacts ovarian cancer survival
Hufnagel, D. H., Khabele, D., Yull, F. E., Hull, P. C., Schildkraut, J. M., Crispens, M. A., & Beeghly-Fadiel, A. C. (2021) · Cancer Epidemiology · doi:10.1016/j.canep.2021.102013 · Cited by 55
Bodywide ecological interventions on cancer
Kroemer, G., McQuade, J. L., Mérad, M., André, F., & Zitvogel, L. (2023) · Nature Medicine · doi:10.1038/s41591-022-02193-4 · Cited by 57
Sarkar, D. K., Zhang, C., Murugan, S., Dokur, M., Boyadjieva, N. I., Ortigüela, M., Reuhl, K. R., & Mojtehedzadeh, S. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1610 · Cited by 55
“Stress has been shown to be a tumor-promoting factor (3-7).”
Cancer’s got nerve: Schwann cells drive perineural invasion
Azam, S. H., & Pecot, C. V. (2016) · Journal of Clinical Investigation · doi:10.1172/jci86801 · Cited by 51
Estrogen- and stress-induced DNA damage in breast cancer and chemoprevention with dietary flavonoid
Yasuda, M. T., Sakakibara, H., & Shimoi, K. (2017) · Genes and Environment · doi:10.1186/s41021-016-0071-7 · Cited by 58
“Chronic restraint stress has also been shown to increase the rate of primary tumor growth and cause primary tumor to become more metastatic in mouse models of breast cancer [70, 71].”
BackgroundBu, S., Wang, Q., Sun, J., Li, X., Gu, T., & Lai, D. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-02906-y · Cited by 51
Bao, R., Wang, S., Liu, X., Tu, K., Liu, J., Huang, X., Liu, C., Zhou, P., & Liu, S. (2024) · Nature Communications · doi:10.1038/s41467-024-45590-8 · Cited by 54
“KEGG showed that the DEGs were mainly enriched in the cAMP signaling pathway in the 2D ES group compared with non-ES group, which is the main pathway of ADRB2 50 .”
Role of endothelial nitric oxide synthase (eNOS) in chronic stress‐promoted tumour growth
Barbieri, A., Palma, G., Rosati, A., Giudice, A., Falco, A., Petrillo, A., Petrillo, M., Bimonte, S., Benedetto, M. D., Esposito, G., et al. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01375.x · Cited by 52
Silencing of p130Cas in Ovarian Carcinoma: A Novel Mechanism for Tumor Cell Death
Nick, A. M., Stone, R. L., Armaiz-Pena, G., Ozpolat, B., Tekedereli, I., Graybill, W. S., Landen, C. N., Villares, G., Vivas-Mejia, P., Bottsford-Miller, J., et al. (2011) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djr372 · Cited by 51
Self-citationSong, H., Saito, E., Sawada, N., Abe, S. K., Hidaka, A., Shimazu, T., Yamaji, T., Goto, A., Iwasaki, M., Sasazuki, S., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-13362-8 · Cited by 56
Hylander, B. L., Gordon, C. J., & Repasky, E. A. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1800621 · Cited by 53
“mice are considered to be at “baseline” and stress protocols all move the “stress needle” from moderate stress to high stress (25, 26, 28, 30, 31).”
BackgroundInfluentialβ-Adrenergic receptor modulation of wound repair
Pullar, C. E., Manabat-Hidalgo, C. G., BOLAJI, R., & Isseroff, R. R. (2008) · Pharmacological Research · doi:10.1016/j.phrs.2008.07.012 · Cited by 53
Nuclear factor-kappa B links carcinogenic and chemopreventive agents
Aggarwal, B. B. (2009) · Frontiers in Bioscience-Scholar · doi:10.2741/s6 · Cited by 51
Zhang, Z., Shao, S., Zhang, Y., Jia, R., Hu, X., Liu, H., Sun, M., Zhang, B., Li, Q., & Wang, Y. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110916 · Cited by 54
Metadata
- Authors
- Thaker, P. H., Han, L. Y., Kamat, A. A., Arevalo, J. M., Takahashi, R., Lu, C., Jennings, N. B., Armaiz-Pena, G., Bankson, J. A., Ravoori, M., Merritt, W. M., Lin, Y. G., Mangala, L. S., Kim, T. J., Coleman, R. L., Landen, C. N., Li, Y., Felix, E., Sanguino, A. M., Newman, R. A., Lloyd, M., Gershenson, D. M., Kundra, V., Lopez-Berestein, G., Lutgendorf, S. K., Cole, S. W., & Sood, A. K.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- University of California, Los Angeles (US)
- University of Iowa (US)
- Corresponding author
- Sood, Anil K
- ORCID
- Venue
- Nature Medicine
- Published
- 2006-07-23
- Volume
- 12
- Issue
- 8
- Pages
- 939-944
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2151356556
- Cited by
- 1,320
- References
- 31
- Citations by year
- 2026: 69 · 2025: 83 · 2024: 100 · 2023: 88 · 2022: 71 · 2021: 82 · 2020: 90 · 2019: 66 · 2018: 64 · 2017: 55 · 2016: 70 · 2015: 74 · 2014: 59 · 2013: 72 · 2012: 63
- FWCI
- 23.64
- Type
- journal article
- Language
- en
- Update notices
- correction (2021-11-19)
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Johnson and Johnson
- National Cancer Institute (CA10929801, U01CA213759, CA-104825, CA 11079301, R01CA104825, P50CA083639)
- National Institute of Allergy and Infectious Diseases (AI 52737, R01AI052737)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Stress, Anesthesia, and Immune Response
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Oncology › Ovarian cancer diagnosis and treatment
- Keywords
- chronic stress, ovarian carcinoma, tumor angiogenesis, tumor growth, beta2-adrenergic receptor, cAMP signaling, protein kinase A, catecholamines, vascular endothelial growth factor, matrix metalloproteinases, tumor invasion, orthotopic xenograft
- MeSH terms
- Animals, Carcinoma, Disease Models, Animal, Drug Combinations, Enzyme Inhibitors, Female, Humans, Isoproterenol, Mice, Nude, Neoplasm Transplantation, Neovascularization, Pathologic, Organ Size, Ovarian Neoplasms, Phthalazines, Pyridines, Radiography, Random Allocation, Stress, Psychological, Terbutaline, Transplantation, Heterologous, Vascular Endothelial Growth Factor A, Cell Line, Tumor, Tumor Burden, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.